Dr. Kyle Parish, MD

NPI: 1881622751
Total Payments
$9,910
2024 Payments
$1,514
Companies
49
Transactions
622
Medicare Patients
5,889
Medicare Billing
$588,781

Payment Breakdown by Category

Food & Beverage$9,893 (99.8%)
Education$17.52 (0.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,893 620 99.8%
Education $17.52 2 0.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,162 61 $0 (2024)
ABBVIE INC. $1,092 76 $0 (2024)
PFIZER INC. $953.73 53 $0 (2024)
Amgen Inc. $931.85 61 $0 (2024)
Novo Nordisk Inc $556.31 36 $0 (2024)
Lilly USA, LLC $513.67 30 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $504.14 33 $0 (2024)
Allergan, Inc. $464.97 41 $0 (2020)
SANOFI-AVENTIS U.S. LLC $385.91 27 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $382.52 22 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,514 82 ABBVIE INC. ($308.67)
2023 $1,377 78 ABBVIE INC. ($247.55)
2022 $1,555 93 ABBVIE INC. ($195.53)
2021 $1,576 103 AbbVie Inc. ($340.63)
2020 $1,290 86 AstraZeneca Pharmaceuticals LP ($245.11)
2019 $907.86 63 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($175.33)
2018 $1,035 71 AstraZeneca Pharmaceuticals LP ($164.10)
2017 $655.56 46 AstraZeneca Pharmaceuticals LP ($114.28)

All Payment Transactions

622 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
12/13/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $16.96 General
Category: Inflammation
12/12/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $5.20 General
Category: NEUROSCIENCE
11/25/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $6.96 General
Category: NEUROSCIENCE
11/19/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $14.52 General
Category: PSYCHIATRY
11/18/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $19.89 General
Category: DIABETES
11/12/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $8.17 General
Category: NEUROSCIENCE
11/12/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $3.96 General
Category: NEUROSCIENCE
11/06/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $21.96 General
Category: Oncology
11/05/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $21.59 General
Category: NEUROSCIENCE
10/30/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $22.20 General
Category: CNS Stimulant for ADHD
10/23/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.77 General
Category: Cardiovascular and Metabolism
10/21/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $21.24 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/15/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $20.81 General
Category: NEUROSCIENCE
10/14/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.82 General
Category: DIABETES
09/27/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $27.13 General
Category: CNS Stimulant for ADHD
09/27/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $3.51 General
Category: CNS Stimulant for ADHD
09/26/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $5.35 General
Category: Bone Health
09/23/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $23.37 General
Category: Psychology/Psychiatric
09/20/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $16.96 General
Category: Inflammation
09/16/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $5.56 General
Category: NEUROSCIENCE
09/09/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $6.69 General
Category: NEUROSCIENCE
09/04/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $19.20 General
Category: DIABETES
08/26/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $21.13 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/23/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $16.96 General
Category: Inflammation
08/22/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $8.35 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 1,396 1,952 $243,075 $141,833
2022 17 1,438 2,095 $261,346 $149,267
2021 15 1,445 2,149 $267,877 $155,180
2020 17 1,610 2,125 $259,851 $142,502
Total Patients
5,889
Total Services
8,321
Medicare Billing
$588,781
Procedure Codes
64

All Medicare Procedures & Services

64 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 288 496 $80,352 $36,315 45.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 304 304 $36,480 $35,280 96.7%
99497 Advance care planning, first 30 minutes Office 2023 268 268 $25,460 $20,140 79.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 143 248 $26,784 $12,314 46.0%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 55 70 $14,000 $9,646 68.9%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 66 179 $11,456 $6,640 58.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 52 66 $13,860 $6,275 45.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 42 91 $13,650 $5,426 39.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 39 53 $8,851 $4,465 50.4%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 15 15 $2,400 $2,304 96.0%
20610 Aspiration and/or injection of fluid from large joint Office 2023 19 35 $4,375 $1,541 35.2%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 11 13 $1,521 $725.88 47.7%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2023 33 38 $1,368 $531.52 38.9%
96372 Injection of drug or substance under skin or into muscle Office 2023 28 34 $1,258 $225.54 17.9%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 33 42 $1,260 $2.98 0.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 294 514 $83,268 $36,667 44.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 312 312 $37,440 $36,048 96.3%
99497 Advance care planning, first 30 minutes Office 2022 253 253 $24,035 $19,787 82.3%
99495 Transitional care management services for problem of moderate complexity Office 2022 58 84 $16,800 $12,886 76.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 168 260 $28,080 $12,648 45.0%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 77 266 $17,024 $7,927 46.6%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 55 69 $14,490 $6,974 48.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 52 122 $18,300 $6,716 36.7%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 39 54 $9,018 $4,314 47.8%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 12 12 $1,920 $1,880 97.9%

About Dr. Kyle Parish, MD

Dr. Kyle Parish, MD is a Family Medicine healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881622751.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Parish, MD has received a total of $9,910 in payments from pharmaceutical and medical device companies, with $1,514 received in 2024. These payments were reported across 622 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($9,893).

As a Medicare-enrolled provider, Parish has provided services to 5,889 Medicare beneficiaries, totaling 8,321 services with total Medicare billing of $588,781. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Adolescent Medicine, Adult Medicine
  • Location Paducah, KY
  • Active Since 06/29/2006
  • Last Updated 08/13/2025
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1881622751

Products in Payments

  • FARXIGA (Drug) $981.36
  • UBRELVY (Drug) $597.22
  • Otezla (Drug) $563.30
  • ELIQUIS (Drug) $538.71
  • XIFAXAN (Drug) $497.48
  • VRAYLAR (Drug) $489.83
  • JARDIANCE (Drug) $337.77
  • SOLIQUA 100/33 (Biological) $332.03
  • NURTEC ODT (Drug) $269.45
  • CHANTIX (Drug) $244.65
  • TRINTELLIX (Drug) $241.12
  • Ozempic (Drug) $235.17
  • QULIPTA (Drug) $215.25
  • ENTRESTO (Drug) $211.26
  • VYVANSE (Drug) $202.80
  • Azstarys (Drug) $189.71
  • Aimovig (Biological) $161.33
  • VIBERZI (Drug) $147.51
  • Kerendia (Drug) $140.66
  • Livalo (Drug) $136.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Paducah